Profund Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
22,436
-6,124
| -21% | -$98K | 0.01% | 596 |
|
|
2025
Q1 | $488K | Buy |
28,560
+5,850
| +26% | +$100K | 0.02% | 480 |
|
|
2024
Q4 | $563K | Sell |
22,710
-7,321
| -24% | -$181K | 0.02% | 456 |
|
|
2024
Q3 | $856K | Buy |
30,031
+3,891
| +15% | +$111K | 0.03% | 365 |
|
|
2024
Q2 | $690K | Sell |
26,140
-18,864
| -42% | -$498K | 0.03% | 398 |
|
|
2024
Q1 | $1.45M | Buy |
45,004
+7,544
| +20% | +$244K | 0.06% | 242 |
|
|
2023
Q4 | $1.58M | Sell |
37,460
-12,409
| -25% | -$523K | 0.07% | 233 |
|
|
2023
Q3 | $1.91M | Buy |
49,869
+4,115
| +9% | +$158K | 0.11% | 155 |
|
|
2023
Q2 | $868K | Sell |
45,754
-14,735
| -24% | -$280K | 0.05% | 347 |
|
|
2023
Q1 | $938K | Buy |
+60,489
| New | +$938K | 0.06% | 316 |
|